Hjem
Marianne Øksness bilde

Marianne Øksnes

Førsteamanuensis
  • E-postMarianne.Oksnes@uib.no
  • Telefon+47 55 97 30 75
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2024). Improving diagnostic precision in primary ovarian insufficiency using comprehensive genetic and autoantibody testing. Human Reproduction. 177-189.
  • Vis forfatter(e) (2023). High-resolution daily profiles of tissue adrenal steroids by portable automated collection. Science Translational Medicine.
  • Vis forfatter(e) (2023). Approach to the Patient: Diagnosis of Primary Adrenal Insufficiency in Adults. Journal of Clinical Endocrinology and Metabolism (JCEM). 269-278.
  • Vis forfatter(e) (2023). Altered biomarkers for cardiovascular disease and inflammation in autoimmune Addison's disease - a cross-sectional study. European Journal of Endocrinology (EJE). 438-447.
  • Vis forfatter(e) (2022). Pulsatile Subcutaneous Hydrocortisone Replacement in Primary Adrenal Insufficiency. Hormone and Metabolic Research. 471-478.
  • Vis forfatter(e) (2022). Premature menopause and autoimmune primary ovarian insufficiency in two international multi-center cohorts. Endocrine Connections. 11 sider.
  • Vis forfatter(e) (2022). Prematur ovarialinsuffisiens. Tidsskrift for Den norske legeforening. 8 sider.
  • Vis forfatter(e) (2021). Sex-Specific Limitations in Physical Health in Primary Adrenal Insufficiency. Frontiers in Endocrinology. 9 sider.
  • Vis forfatter(e) (2021). Primary ovarian insufficiency in women with Addison's disease. Journal of Clinical Endocrinology and Metabolism (JCEM). e2656-e2663.
  • Vis forfatter(e) (2021). Potential Transcriptional Biomarkers to Guide Glucocorticoid Replacement in Autoimmune Addison's Disease. Journal of the Endocrine Society (JES). 1-10.
  • Vis forfatter(e) (2020). Residual Corticosteroid Production in Autoimmune Addison Disease. Journal of Clinical Endocrinology and Metabolism (JCEM). 2430-2441.
  • Vis forfatter(e) (2020). Current Management and Outcome of Pregnancies in Women with Adrenal Insufficiency: Experience from a Multicenter Survey. Journal of Clinical Endocrinology and Metabolism (JCEM). E2853-E2863.
  • Vis forfatter(e) (2018). The short cosyntropin test revisited: new normal reference range using LC-MS/MS. Journal of Clinical Endocrinology and Metabolism (JCEM). 1696-1703.
  • Vis forfatter(e) (2017). Clues for early detection of autoimmune Addison's disease - myths and realities. Journal of Internal Medicine. 190-199.
  • Vis forfatter(e) (2017). Assessment of diabetic polyneuropathy in Zanzibar: Comparison between traditional methods and an automated point-of-care nerve conduction device. Journal of Clinical and Translational Endocrinology. 9-14.
  • Vis forfatter(e) (2016). Effect of a pre-exercise hydrocortisone dose on short-term physical performance in female patients with primary adrenal failure. European Journal of Endocrinology (EJE). 97-105.
  • Vis forfatter(e) (2015). Preoperative octreotide therapy and surgery in acromegaly: associations between glucose homeostasis and treatment response. Endocrine. 10 sider.
  • Vis forfatter(e) (2015). Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency. European Journal of Endocrinology (EJE). 619-626.
  • Vis forfatter(e) (2015). Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy. Clinical Endocrinology. 28-35.
  • Vis forfatter(e) (2014). Preoperative octreotide treatment of acromegaly: Long-term results of a randomised controlled trial. European Journal of Endocrinology (EJE). 229-235.
  • Vis forfatter(e) (2014). Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of Addison's disease: A randomized clinical trial. Journal of Clinical Endocrinology and Metabolism (JCEM). 1665-1674.
  • Vis forfatter(e) (2012). Quality of life in European patients with Addison's Disease: Validity of the disease-specific questionnaire AddiQoL. Journal of Clinical Endocrinology and Metabolism (JCEM). 568-576.
  • Vis forfatter(e) (2012). Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency. European Journal of Endocrinology (EJE). 507-516.
  • Vis forfatter(e) (2010). Development of a Disease-Specific Quality of Life Questionnaire in Addison's Disease. Journal of Clinical Endocrinology and Metabolism (JCEM). 545-551.
  • Vis forfatter(e) (2009). Gamma knife stereotactic radiosurgery of Nelson syndrome. European Journal of Endocrinology (EJE). 143-148.
  • Vis forfatter(e) (2009). Development of a Disease-Specific Quality of Life Questionnaire in Addison’s Disease. Journal of Clinical Endocrinology and Metabolism (JCEM).
Doktorgradsavhandling
  • Vis forfatter(e) (2014). Glucocorticoid Treatment and Quality of Life in Addison’s disease.
Digitale læremidler
  • Vis forfatter(e) (2022). Diabetes for helsepersonell.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2023). Plasma-Metanephrines in Patients with Autoimmune Addison’s Disease with and without Residual Adrenocortical Function. Journal of Clinical Medicine. 1-10.
  • Vis forfatter(e) (2015). Optimal glucocorticoid replacement in adrenal insufficiency. Baillière's Best Practice & Research. Clinical Endocrinology & Metabolism. 3-15.

Se fullstendig oversikt over publikasjoner i CRIStin.